More than a marine propeller - the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus

International Journal of Medical Microbiology

Volumn 302, Issue 7-8, 2012, Pages 304-314

  Troge, Anja ^a   Scheppach, Wolfgang ^b   Schroeder, Bjoern O ^c   Rund, Stefan A ^a   Heuner, Klaus ^d   Wehkamp, Jan ^c   Stange, Eduard F ^c   Oelschlaeger, Tobias A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Division of Gastroenterology/Rheumatology   (Germany)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Adhesion; Escherichia coli Nissle 1917; Flagella; Human mucus; Probiotic

Indexed keywords

ADHESIN; BETA DEFENSIN 2; FLAGELLIN; GLUCONIC ACID; MUCIN 2; PROBIOTIC AGENT;

ANIMAL TISSUE; ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BINDING KINETICS; COLON BIOPSY; CONTROLLED STUDY; DRUG MECHANISM; EPITHELIUM CELL; ESCHERICHIA COLI; ESCHERICHIA COLI NISSLE 1917; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MUCUS; NONHUMAN; PHENOTYPE; PROTEIN DOMAIN; WILD TYPE;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; ESCHERICHIA COLI; FEMALE; FLAGELLA; GLUCONATES; HUMANS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MUCUS; SWINE;

EID: 84870572403     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2012.09.004     Document Type: Article

References (58)

1. Allen A. Structure and function in gastric mucus. Adv. Exp. Med. Biol. 1977, 89:283-299.
2. Altenhoefer A., Oswald S., Sonnenborn U., Enders C., Schulze J., Hacker J., Oelschlaeger T.A. The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens. FEMS Immunol. Med. Microbiol. 2004, 40:223-229.
3. Arora S.K., Ritchings B.W., Almira E.C., Lory S., Ramphal R. The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion. Infect. Immun. 1998, 66:1000-1007.
4. Atuma C., Strugala V., Allen A., Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G922-G929.
5. Barker C.S., Pruss B.M., Matsumura P. Increased motility of Escherichia coli by insertion sequence element integration into the regulatory region of the flhD operon. J. Bacteriol. 2004, 186:7529-7537.
6. Bishop A., House D., Perkins T., Baker S., Kingsley R.A., Dougan G. Interaction of Salmonella enterica serovar Typhi with cultured epithelial cells: roles of surface structures in adhesion and invasion. Microbiology 2008, 154:1914-1926.
7. Boekhorst J., Helmer Q., Kleerebezem M., Siezen R.J. Comparative analysis of proteins with a mucus-binding domain found exclusively in lactic acid bacteria. Microbiology 2006, 152:273-280.
8. Boudeau J., Glasser A.L., Julien S., Colombel J.F., Darfeuille-Michaud A. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease. Aliment. Pharmacol. Ther. 2003, 18:45-56.
9. Bruckschen E., Horosiewicz H. Chronische Obstipation. Vergleich von mikrobiologischer Therapie und Lactulose. Münch. Med. Wochenschr. 1994, 16:241-245.
10. Cheikhyoussef A., Pogori N., Chen W., Zhang H. Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application. Int. J. Food Microbiol. 2008, 125:215-222.
11. Chilcott G.S., Hughes K.T. Coupling of flagellar gene expression to flagellar assembly in Salmonella enterica serovar Typhimurium and Escherichia coli. Microbiol. Mol. Biol. Rev. 2000, 64:694-708.
12. Cohen P.S., Arruda J.C., Williams T.J., Laux D.C. Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect. Immun. 1985, 48:139-145.
13. Coic Y.M., Baleux F., Poyraz O., Thibeaux R., Labruyere E., Chretien F., Sobhani I., Lazure T., Wyplosz B., Schneider G., Mulard L., Sansonetti P.J., Marteyn B.S. Design of a specific colonic mucus marker using a human commensal bacterium cell surface domain. J. Biol. Chem. 2012, 287:15916-15922.
14. Collado M.C., Grzeskowiak L., Salminen S. Probiotic strains and their combination inhibit in vitro adhesion of pathogens to pig intestinal mucosa. Curr. Microbiol. 2007, 55:260-265.
15. Corr S.C., Li Y., Riedel C.U., O'Toole P.W., Hill C., Gahan C.G. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7617-7621.
16. Datsenko K.A., Wanner B.L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6640-6645.
17. Duan Q., Zhou M., Zhu X., Bao W., Wu S., Ruan X., Zhang W., Yang Y., Zhu J., Zhu G. The flagella of F18ab Escherichia coli is a virulence factor that contributes to infection in a IPEC-J2 cell model in vitro. Vet. Microbiol. 2012, 160:132-140.
18. Eden C.S., Hansson H.A. Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells. Infect. Immun. 1978, 21:229-237.
19. Erdem A.L., Avelino F., Xicohtencatl-Cortes J., Giron J.A. Host protein binding and adhesive properties of H6 and H7 flagella of attaching and effacing Escherichia coli. J. Bacteriol. 2007, 189:7426-7435.
20. Finlay B.B., Falkow S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 1997, 61:136-169.
21. Fox J.T., Drouillard J.S., Shi X., Nagaraja T.G. Effects of mucin and its carbohydrate constituents on Escherichia coli O157 growth in batch culture fermentations with ruminal or fecal microbial inoculum. J. Anim. Sci. 2009, 87:1304-1313.
22. Gersemann M., Wehkamp J., Stange E.F. Innate immune dysfunction in inflammatory bowel disease. J. Intern. Med. 2012, 271:421-428.
23. Gill H., Prasad J. Probiotics, immunomodulation, and health benefits. Adv. Exp. Med. Biol. 2008, 606:423-454.
24. Grozdanov L., Raasch C., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Dobrindt U. Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 2004, 186:5432-5441.
25. Hamer H.M., Jonkers D.M., Loof A., Vanhoutvin S.A., Troost F.J., Venema K., Kodde A., Koek G.H., Schipper R.G., van Heerde W.L., Brummer R.J. Analyses of human colonic mucus obtained by an in vivo sampling technique. Dig. Liver Dis. 2009, 41:559-564.
26. Helwig U., Lammers K.M., Rizzello F., Brigidi P., Rohleder V., Caramelli E., Gionchetti P., Schrezenmeir J., Foelsch U.R., Schreiber S., Campieri M. Lactobacilli, bifidobacteria and E. coli Nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 2006, 12:5978-5986.
27. Henker J., Laass M., Blokhin B.M., Bolbot Y.K., Maydannik V.G., Elze M., Wolff C., Schulze J. The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur. J. Pediatr. 2007, 166:311-318.
28. Henker J., Laass M.W., Blokhin B.M., Maydannik V.G., Bolbot Y.K., Elze M., Wolff C., Schreiner A., Schulze J. Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers. Pediatr. Infect. Dis. J. 2008, 27:494-499.
29. Hernandes R.T., Velsko I., Sampaio S.C., Elias W.P., Robins-Browne R.M., Gomes T.A., Giron J.A. Fimbrial adhesins produced by atypical enteropathogenic Escherichia coli strains. Appl. Environ. Microbiol. 2011, 77:8391-8399.
30. Hueck C.J. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 1998, 62:379-433.
31. Ingrassia I., Leplingard A., Darfeuille-Michaud A. Lactobacillus casei DN-114 001 inhibits the ability of adherent-invasive Escherichia coli isolated from Crohn's disease patients to adhere to and to invade intestinal epithelial cells. Appl. Environ. Microbiol. 2005, 71:2880-2887.
32. Isaacson R.E., Fusco P.C., Brinton C.C., Moon H.W. In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factors. Infect. Immun. 1978, 21:392-397.
33. Jäger S., Stange E.F., Wehkamp J. Antimicrobial peptides in gastrointestinal inflammation. Int. J. Inflam. 2010, 2010:910283.
34. Johansson M.E., Larsson J.M., Hansson G.C. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(Suppl. 1):4659-4665.
35. Johansson M.E., Thomsson K.A., Hansson G.C. Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein. J. Proteome Res. 2009, 8:3549-3557.
36. Juge N. Microbial adhesins to gastrointestinal mucus. Trends Microbiol. 2012, 20:30-39.
37. LaVallie E.R., Stahl M.L. Cloning of the flagellin gene from Bacillus subtilis and complementation studies of an in vitro-derived deletion mutation. J. Bacteriol. 1989, 171:3085-3094.
38. Lillehoj E.P., Kim B.T., Kim K.C. Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am. J. Physiol. Lung Cell. Mol. Physiol. 2002, 282:L751-L756.
39. Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., Hultgren S.J. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000, 19:2803-2812.
40. Miranda R.L., Conway T., Leatham M.P., Chang D.E., Norris W.E., Allen J.H., Stevenson S.J., Laux D.C., Cohen P.S. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect. Immun. 2004, 72:1666-1676.
41. Möllenbrink M., Bruckschen E. Behandlung der chronischen Obstipation mit physiologischen Escherichia coli Bakterien. Med. Klin. 1994, 89:587-593.
42. Ng S.C., Hart A.L., Kamm M.A., Stagg A.J., Knight S.C. Mechanisms of action of probiotics: recent advances. Inflamm. Bowel Dis. 2009, 15:300-310.
43. Oelschlaeger T.A. Mechanisms of probiotic actions - a review. Int. J. Med. Microbiol. 2010, 300:57-62.
44. Ohland C.L., Macnaughton W.K. Probiotic bacteria and intestinal epithelial barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G807-G819.
45. Ramos H.C., Rumbo M., Sirard J.C. Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12:509-517.
46. Roos S., Jonsson H. A high-molecular-mass cell-surface protein from Lactobacillus reuteri 1063 adheres to mucus components. Microbiology 2002, 148:433-442.
47. Sanchez B., Arias S., Chaignepain S., Denayrolles M., Schmitter J.M., Bressollier P., Urdaci M.C. Identification of surface proteins involved in the adhesion of a probiotic Bacillus cereus strain to mucin and fibronectin. Microbiology 2009, 155:1708-1716.
48. Sanchez B., Lopez P., Gonzalez-Rodriguez I., Suarez A., Margolles A., Urdaci M.C. A flagellin-producing Lactococcus strain: interactions with mucin and enteropathogens. FEMS Microbiol. Lett. 2011, 318:101-107.
49. Schierack P., Kleta S., Tedin K., Babila J.T., Oswald S., Oelschlaeger T.A., Hiemann R., Paetzold S., Wieler L.H. E. coli Nissle 1917 affects Salmonella adhesion to porcine intestinal epithelial cells. PLoS One 2011, 6:e14712.
50. Schlee M., Wehkamp J., Altenhoefer A., Oelschlaeger T.A., Stange E.F., Fellermann K. Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 2007, 75:2399-2407.
51. Schultz M. Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm. Bowel Dis. 2008, 14:1012-1018.
52. Sonnenborn U., Schulze J. The non-pathogenic Escherichia coli strain Nissle 1917 - features of a versatile probiotic. Microb. Ecol. Health Dis. 2009, 21:122-158.
53. Soutourina O.A., Bertin P.N. Regulation cascade of flagellar expression in Gram-negative bacteria. FEMS Microbiol. Rev. 2003, 27:505-523.
54. Tasteyre A., Barc M.C., Collignon A., Boureau H., Karjalainen T. Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect. Immun. 2001, 69:7937-7940.
55. Tuomola E.M., Ouwehand A.C., Salminen S.J. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol. 1999, 26:137-142.
56. Wehkamp J., Harder J., Wehkamp K., Wehkamp von Meissner B., Schlee M., Enders C., Sonnenborn U., Nuding S., Bengmark S., Fellermann K., Schröder J.M., Stange E.F. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect. Immun. 2004, 72:5750-5758.
57. Wehkamp J., Schmid M., Fellermann K., Stange E.F. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukoc. Biol. 2005, 77:460-465.
58. Yonekura K., Maki-Yonekura S., Namba K. Complete atomic model of the bacterial flagellar filament by electron cryomicroscopy. Nature 2003, 424:643-650.